(Q43622609)

25 November 2017

Magnetic resonance spectroscopy of the malignant prostate gland after radiotherapy: a histopathologic study of diagnostic validity (English)

1 reference

25 November 2017

0 references

Menard C

1

1 reference

25 November 2017

Smith IC

2

1 reference

25 November 2017

Somorjai RL

3

1 reference

25 November 2017

Leboldus L

4

1 reference

25 November 2017

Patel R

5

1 reference

25 November 2017

Littman C

6

1 reference

25 November 2017

Robertson SJ

7

1 reference

25 November 2017

Bezabeh T

8

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 June 2001

1 reference

International Journal of Radiation Oncology Biology Physics

25 November 2017

1 reference

25 November 2017

50

1 reference

25 November 2017

317-323

1 reference

25 November 2017

2

1 reference

Prostate biopsy after definitive treatment by interstitial 125iodine implant or external beam radiation therapy

25 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901480-8

7 January 2021

Effect of local tumor control on distant metastasis and survival in prostatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901480-8

7 January 2021

Technical and tumor-related factors affecting outcome of definitive irradiation for localized carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901480-8

7 January 2021

Consensus statements on radiation therapy of prostate cancer: guidelines for prostate re-biopsy after radiation and for radiation therapy with rising prostate-specific antigen levels after radical prostatectomy. American Society for Therapeutic Radi

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901480-8

7 January 2021

Dose escalation with 3D conformal treatment: five year outcomes, treatment optimization, and future directions.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901480-8

7 January 2021

Defining the appropriate radiation dose for pretreatment PSA < or = 10 ng/mL prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901480-8

7 January 2021

Survival advantage from higher-dose radiation therapy for clinically localized prostate cancer treated on the Radiation Therapy Oncology Group trials

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901480-8

7 January 2021

Magnetic resonance imaging of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901480-8

7 January 2021

Prostate cancer: prediction of extracapsular extension with endorectal MR imaging and three-dimensional proton MR spectroscopic imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901480-8

7 January 2021

The use of 1H magnetic resonance spectroscopy in inflammatory bowel diseases: distinguishing ulcerative colitis from Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901480-8

7 January 2021

Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901480-8

7 January 2021

In vivo proton magnetic resonance spectroscopy of diseased prostate: spectroscopic features of malignant versus benign pathology

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901480-8

7 January 2021

Prostate cancer: metabolic response to cryosurgery as detected with 3D H-1 MR spectroscopic imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901480-8

7 January 2021

Imaging and radiotherapy of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901480-8

7 January 2021

Treatment planning for prostate implants using magnetic-resonance spectroscopy imaging.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901480-8

7 January 2021

Computerized consensus diagnosis: a classification strategy for the robust analysis of MR spectra. I. Application to 1H spectra of thyroid neoplasms.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901480-8

7 January 2021

A simple procedure for obtaining high-quality nmr spectra of semiquantitative value from small tissue specimens: cervical biopsies

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901480-8

7 January 2021

Keratin immunoreactivity as an aid to the diagnosis of persistent adenocarcinoma in irradiated human prostates

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901480-8

7 January 2021

Cytological grading of therapy-induced tumor regression in prostatic carcinoma: proposal of a new system

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901480-8

7 January 2021

Near-optimal region selection for feature space reduction: novel preprocessing methods for classifying MR spectra.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901480-8

7 January 2021

Postradiotherapy prostate biopsies: what do they really mean? Results for 498 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901480-8

7 January 2021

Routine prostate biopsies following radiotherapy for prostate cancer: results for 226 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901480-8

7 January 2021

The clinical significance of a positive post-irradiation prostatic biopsy without metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901480-8

7 January 2021

Radiation injury of the normal and neoplastic prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901480-8

7 January 2021

Characterization of human prostate cancer, benign prostatic hyperplasia and normal prostate by in vitro 1H and 31P magnetic resonance spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901480-8

7 January 2021

Concepts of citrate production and secretion by prostate: 2. Hormonal relationships in normal and neoplastic prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901480-8

7 January 2021

Citrate alterations in primary and metastatic human prostatic adenocarcinomas: 1H magnetic resonance spectroscopy and biochemical study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901480-8

7 January 2021

Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging--clinicopathologic study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901480-8

7 January 2021

Increased choline signal coinciding with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopy imaging study.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901480-8

7 January 2021

Serial proton magnetic resonance spectroscopy imaging of glioblastoma multiforme after brachytherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901480-8

7 January 2021

Experience with carbon-11 choline positron emission tomography in prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901480-8

7 January 2021

Proceedings of a National Cancer Institute workshop: MR spectroscopy and tumor cell biology

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901480-8

7 January 2021

10.1016/S0360-3016(01)01480-8

Identifiers

DOI

1 reference

25 November 2017

1 reference